Publicaciones en colaboración con investigadores/as de Corporació Sanitària Parc Taulí (3)

2014

  1. Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumours

    Clinical and Translational Oncology, Vol. 16, Núm. 3, pp. 322-329

2013

  1. Phase II trial of sequential subcutaneous interleukin-2 plus interferon alpha followed by sorafenib in renal cell carcinoma (RCC)

    Clinical and Translational Oncology, Vol. 15, Núm. 9, pp. 698-704

2011

  1. Phase II study of sunitinib as first-line treatment of urothelial cancer patients ineligible to receive cisplatin-based chemotherapy: Baseline interleukin-8 and tumor contrast enhancement as potential predictive factors of activity

    Annals of Oncology, Vol. 22, Núm. 12, pp. 2646-2653